I think the tech is sexy with good global reach and really just needs to see top line growth. At the 10c equivalent market cap it was a steal! However I would be very surprised if they are able to become cash flow positive within the next 24 months. The existing product lines would be amazing as a plug in for some big pharma and we just take a royalty on sales rather than appointing small distributors here and there that hasn’t done much in terms of actual top line growth IMO
OSX Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)